Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001204439 | SCV001375645 | uncertain significance | not provided | 2022-10-24 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 625 of the MTTP protein (p.Pro625Leu). This variant is present in population databases (rs146045390, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with MTTP-related conditions. ClinVar contains an entry for this variant (Variation ID: 935777). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MTTP protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
New York Genome Center | RCV001833797 | SCV004176079 | uncertain significance | Abetalipoproteinaemia | 2023-03-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003898195 | SCV004715026 | likely benign | MTTP-related disorder | 2022-03-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV001833797 | SCV002082447 | uncertain significance | Abetalipoproteinaemia | 2020-02-13 | no assertion criteria provided | clinical testing |